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A Model of the Molecular Aggregate
Processes of Hemoglobin S.
Absence of Cristallization
Carlos Cabal-Mirabal∗ Iván Ruiz-Chaveco∗∗
Abstract. The molecular aggregate formation mechanisms play a major role
in the interpretation of the pathophysiology of Sickle Cell disease and in
the selection of the therapeutic strategies to follow.
A mechanism and a mathematical model are proposed. The model postu-
lates the existence of defective microtubules formed by deoxy hemoglobin S
and oxy hemoglobin S, and explains the dependence of polymerization on
hemoglobin concentration, temperature, and partial oxygen pressure. The
analysis focuses on the polymerization of hemoglobin S in the absence of
crystallization. The action of other kinds of hemoglobin in the molecular
aggregate formation process can be explained.
Resumen. Los mecanismos de formación molecular agregada desempeña
un papel importante en la interpretación de la patoﬁsiología de la anemia
de células falciformes (o anemia drepanocítica), y en la selección de las
estrategias terapéuticas a seguir.
Aquí se propone un mecanismo y un modelo matemático. el modelo postula
la existencia de microtúbulos defectivos formados por deoxihemoglobina
S y oxihemoglobina S, y explica la dependencia de la polimerización de
la concentración de hemoglobina, la temperatura y la presión parcial de
oxígeno. El análisis hace énfasis en la polimerización de hemoglobina S en
la ausencia de cristalización. La acción de otras clases de hemoglobinas en
la formación molecular agregada puede ser explicada.
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1. Introduction
Sickle-cell anemia remains a health problem worldwide [1]. This genetic disease is due to
an alteration in the hemoglobin amino-acids chain, which leads to the polymerization of
hemoglobin S (HbS) under low oxygenation conditions, the deformation of red blood cells,
changes in membrane permeability and elasticity, modiﬁcations in blood rheology and
several other physiological processes, thus producing the vase-occlusive crises that cause
an intense, progressive deterioration of the patients, resulting in their death, generally
at early ages [1].
Several factors determine the polymerization of deoxygenated HbS. Some of them are:
the HbS oxygenation degree [2]–[4], HbS concentration [HbS] [2, 5, 6], temperature [7, 8],
the pH of the solution [2, 6], and the presence of other hemoglobins [5, 9]–[12].
The main factor determining HbS polymerization is partial oxygen pressure p, because the
oxygenated HbS–deoxygenated HbS ratio (oxyHbS/deoxyHbS) depends on it. Increasing
temperature favors the formation of deoxyHbS aggregates; so does an increase in [HbS].
However, for this phenomenon to occur, a deoxyHbS concentration [deoxyHbS] greater
than a minimum value (α) is necessary [2, 3].
An interesting experimental fact is that, even at a low p, a fraction of deoxyHbS is not
in molecular aggregate state and decreases with the increase of p [2, 3]. The molecular
aggregates formation of HbS is a reversible phenomenon, since deoxyHbS aggregates
dissolve under oxygenation or with a temperature decrease [1, 2, 3, 5].
The inhibiting eﬀect of mixing HbS with other types of Hemoglobin (HbA, HbF, HbA2)
on polymerization is well known [2, 6, 9]–[12]. The increase of HbA and HbF in the total
hemoglobin of sickle-cell anemia patients has been associated with a decrease of clinical
severity [1, 2, 12]–[14].
HbS polymers have been studied using diﬀerent techniques, such as X–ray diﬀraction
[2, 15]–[17] and Electronic Microscopy (EM) [2, 18]–[22]. The structure of HbS molec-
ular aggregates has been determined by EM [2, 20, 21], showing the structure of ﬁbers
(microtubules, µT ) formed by 14-16 hemoglobin molecules. The dominions formation
has also been observed inside erythrocytes in advanced gelation state. The kinetics of
the microtubules and dominions formation has not been explained in detail [2, 19]–[24].
The molecular mechanisms of polymerization and depolymerization play a major role in
the interpretation of the pathophysiology of the disease and in the selection of therapeutic
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strategies to follow [1, 2, 3, 23]. Diﬀerent mechanisms and models have been proposed
[2, 3, 22]–[30], which allow the interpretation of numerous phenomena.
In this paper, a polymerization mechanism and model are presented assuming that defec-
tive structural units are formed. The structural data related to the diﬀerent number of
strands forming the HbS ﬁbers can be explained. The model also describes the inﬂuence
of [HbS] and p on the polymerization process and the role of other hemoglobins, including
HbS itself, whenever its three-dimensional structure or contact points are modiﬁed.
2. Method
Let us assume that HbS can appear in red blood cells in the following states (Figure 1):
HbS Oxygenated in a) MonomersM ; b) Defective microtubule structural units
µTu∆.
HbS Deoxygenated in a) Monomers M , b) Microtubule structural units µTu,
c) Microtubules µT , d) Domains D.
Figure 1. Diﬀerent aggregation states of Hemoglobin S in the polymerization process.
Considering the hypothesis that µTu (formed wholly by deoxyHbS molecules), coex-
ist with µTu∆ (formed by both deoxy and oxyHbS) unable to form new tubules, the
following mechanism is proposed:
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(I). 1 (deoxyHbS)M + 4 O2 fast−−−−−→ 1 (oxyHbS)M (in any state).
(II). K (oxyHbS)M + nγ (deoxyHbS)M + n (deoxyHbS)M slow−−−−−→ 1µTu+KµTu∆.
(III). a) µTu fast−−−−−→ µT slow−−−−−→ n (deoxyHbS)M .
b) KµTu∆ fast−−−−−→ K (oxyHbS)M + nγ (deoxyHbS)M .
(IV). a) When the [deoxyHbS] in µT is greater than or equal to β1 and the [deoxy-
HbS] in D is lower than β2:
µT very slow−−−−−−−−−→←−−−−−− D.
b) When the [deoxyHbS] in D is greater that β2:
µT + (deoxyHbS)M
very slow
−−−−−−−−−→←−−−−−− D.
When the [deoxyHbS] µT is lower than β1 and the [deoxyHbS] in D is lower
than β2, the crystallization process is not favorable:
D very slow−−−−−−−−−→←−−−−−− µT + (deoxyHbS)M .
Processes (II) - (IIIa) constitute the polymerization mechanism, which includes the
formation of µTu∆. nα = n+nγ = n (1 + γ). Where α: minimum [deoxyHbS] necessary
for polymerization to occur; n: number of HbS molecules that form the µTu. As α
can range from 1 to approximately 2, it is generally taken as such in the model, i.e.,
α = 2 + δ, where |δ| < 1. This allows us to explain the experimental data related to
diﬀerent numbers of molecules forming the µT .
The crystallization mechanism is described by (IV). It has been supposed that the HbS
change from µT state to D, only occurs when the [deoxyHbS] in µT surpasses a threshold
β1. Once small deoxyHbS dominions exist, they can grow either by addition of isolated
deoxyHbS monomers or by addition of µTu. The D shall be disintegrated when the
[deoxyHbS] in µT is lower than β1 and the [deoxyHbS] in dominions decreases below its
threshold value β2. Reactions I - IV are in agreement with the double nucleation model
described (homogeneous and heterogeneous processes) [2].
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3. Results and discussion
The following mathematical model is proposed. Assuming the quick processes (I) and
(III) as instantaneous compared to the rest, then the mass conservation law is stated
by:
x(t) + n · y(t) + n · z(t) + w(p) = N, (1)
where x(t): [deoxyHbS] in monomer state or as part of µTu∆; n ·y(t): [deoxyHbS] in µT ;
n · z(t): [deoxyHbS] in D; w(p): [oxyHbS] depending on the p inside the erythrocytes;
N : total [HbS]. In turn, the equation system describing the kinetic process is:
dx
dt = −n · P (x) − (c− d) x+ n · b · y, (2)
dy
dt = − (b+ e− f) · y + P (x) , (3)
dz
dt =
�c− d
n
�
· x+ (e− f) · y, (4)
where ai (i = 1, 2, · · · , 2n), b, c, d, e and f , are the reaction coeﬃcients; ai: polymer-
ization; b: depolymerization; c: crystallization by the addition of deoxyHbS monomers;
d: decrystallization by separation of monomers; e: crystallization by addition of µT ; f :
decrystallization by separation of µT .
P (x) =
2n
�
i=1
ai · xi
is a Polymerization function.
In this paper the fundamental properties of the solution of the (2)–(4) equation system
are discussed and a phenomenological interpretation of these properties is given. The
(1)–(4) nonlineal ordinary diﬀerential equation system has not been solved because of its
complexity. However, several speciﬁc cases are interesting and simple enough to study
them separately. The analysis focuses on the Polymerization of HbS in the absence of
crystallization.
If at a given moment there are no dominions and at every subsequent moment [HbS]< β1
in µT , then crystallization will never occur and z(t) = 0 . Thereby
N = x(t) + n · y(t) + w(p), (5)
dx
dt = −n · P (x) + n · b · y, (6)
dy
dt = −b · y + P (x) . (7)
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The solution of the (6), (7) system is expressed as follows:
x (t) + n · y (t) = Q = const, (8)
i.e., a set of straight lines with −1/n slope. If we substitute (8) in (5), we get w(p) =
N−Q, which indicates that [oxyHbS] is constant in this speciﬁc case. This system has an
indeﬁnite number of equilibrium positions, which can be seen in the following equation:
y = P [x(t)]b (9)
If the initial condition x(t0) = x0, y(t0) = y0 is met, after a considerably long time,
the solution of the (6)–(7) system approaches curve (9), moving across a set of straight
lines with −1/n slope (see Figure 2A). This guarantees the stability of the equilibrium
positions. In other words, if there is no crystallization, the [deoxyHbS] in monomer state
and forming part of µT tends to ﬁxed values, whether these initial conditions are above
or below the curve (9). A small increase in total [HbS] or a small decrease of p produces
an increase of the [deoxyHbS] in µT [2]. If the temperature rises [2, 3], the an/b ratio in
(9) should grow, and so will y (τ). The stable solution of the (5)–(7) system can explain
another experimental fact. The y (τ) /x (τ) ratio decreases with the increase of p, not
only because y (τ) falls but also because x (τ) grows simultaneously [5]. This is illustrated
in Figure 2.
A B
Figure 2. Dependence of the deoxyHbS concentration in microtubules y(t) at two extreme ratios
of polymerization and depolymerization coeﬃcients a/b (Figure 2A) and at two diﬀerent partial
oxygen pressures p (Figure 2B). This system has an indeﬁnite number of equilibrium positions
moving across a set of straight lines with −1/n slope (2A). If p rises, then x(τ ) increases while
y(τ ) will decrease. Consequently, the ratio y(τ )/x(τ ) will decrease very fast (2B).
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The parameter α was introduced in the model of the HbS molecular aggregate formation
process.
It should be interpreted as follows: When p = 0 and all the HbS is deoxygenated,
γ = 0, then oxyHbS molecules able to participate in the formation of µTu∆ do not
exist. Therefore, only n molecules of deoxyHbS are necessary to form correct structural
units. On the other hand, when p �= 0, then γ �= 0, i.e., when a correct structural unit is
formed (by n deoxyHbS molecules), K ′ defective units should be formed (by a total of
nγ deoxyHbS molecules). With the increase of p, the probability of interaction between
oxy and deoxy molecules also increases. Then, at least one of the oxyHbS molecules
will be part of a µTu∆, instead of a correct one. In other words, γ(p = 0) = 0 and
α(p = 0) = 1 and both increase when p grows. From another viewpoint, when HbS is
highly deoxygenated (p = 0), reaction (IIIb) is negligible and only correct structural units
inﬂuence the polymerization–depolymerization equilibrium. On the other hand, when
HbS is too oxygenated, reaction (IIIa) is negligible, and the defective structural units
determine the polymerization–depolymerization equilibrium. The number of molecules
(nα) forming the µTu varies according to the values of p at which these experiments
are carried out. The dependence of α on p discussed above implies that the increase of
[deoxyHbS] in µT produced by an increase in the total [HbS] is much more abrupt than
that caused by a decrease of p.
Polymerization speed:
Supposing that under certain conditions the polymerization process is dominant and
depolymerization is negligible, a2n ≫ b, and considering that P (x) is determined by the
last term a2n, then the (5),(6), (7) system approximately remains as follows:
dx
dt = −m · a2nx
2n, (10)
dy
dt = a2nx
2n. (11)
For arbitrary initial conditions (x0, y0), the solution of (10) is
x (t) =
� 1
Bt+A
�1/C
, (12)
where ﬁx A, B and C, A = xC0 ; B = nCa2n; C = 2n− 1.
Then in this speciﬁc case after a considerably long time (τ ≫ 1), the total polymerization
of HbS will occur and the following expression can be obtained:
y (t) =
� 1
Bt+A
�1/C
+ x0n + y0. (13)
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last term a2n, then the (5),(6), (7) system approximately remains as follows:
dx
dt = −m · a2nx
2n, (10)
dy
dt = a2nx
2n. (11)
For arbitrary initial conditions (x0, y0), the solution of (10) is
x (t) =
� 1
Bt+A
�1/C
, (12)
where ﬁx A, B and C, A = xC0 ; B = nCa2n; C = 2n− 1.
Then in this speciﬁc case after a considerably long time (τ ≫ 1), the total polymerization
of HbS will occur and the following expression can be obtained:
y (t) =
� 1
Bt+A
�1/C
+ x0n + y0. (13)
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Expressions (12) and (13) can be used experimentally for the quantitative determination
of a2n.
4. Conclusions
The polymerization process can be described by a non-lineal ordinary diﬀerential equation
system. The solution has an indeﬁnite number of equilibrium positions. In other words,
if there is no crystallization, the deoxyHbS concentration in monomer state and forming
part of microtubules µT tends to ﬁxed values. A qualitative discussion properties of
the solution to the mathematical model corresponding to the HbS molecular aggregate
formation mechanisms is proposed.
The existences of defective microtubules formed by deoxyHbS and oxyHbS make possible
explain the dependence of polymerization on HbS concentration, temperature and partial
oxygen pressure. The number of molecules (nα) forming the microtubule units µTu
varies according to the values of partial oxygen pressure p at which these experiments
are carried out. The increase of deoxyHbS concentration in microtubules µT produced
by an increase in the total HbS concentration is much more abrupt than that caused by
a decrease of p, which is in agreement whit the literature.
The action of other types of hemoglobin in the molecular aggregation process forms defec-
tive tubules with HbS, whose stability is considerably lower. It is possible to understand
that the action of some chemical compounds (speciﬁcally the Vanillin) forming a rela-
tively stable link to hemoglobin in the polymerization process, increase the delay time
[31]. This fact has important implications in the therapeutic strategies. The selection
of the therapeutic strategy to follow must aim at reducing the ai/bi ratios, which would
lead to the control of the parameters determining polymer formation: the molecular basis
of the pathophysiology of the disease.
The conclusions derived from the discussion above are in accord with the experimental
data known. Future papers will deal with models that supplement the one presented
here and will include crystallization.
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Sobre la curvatura escalar de S2 × S2
Claudia Granados Pinzón∗
Resumen. En este trabajo se presenta una alternativa para hallar el tensor
de curvatura de S2 × S2, a ﬁn de utilizarlo en el cálculo de la curvatura
escalar en cualquier punto dado de esta variedad riemanniana.
Abstract. In this paper we will show an alternative form to ﬁnd the cur-
vature tensor of S2 × S2, in order to use it in the calculation of the scalar
curvature at any given point of this riemannian manifold.
1. Introducción
Considérese la variedad riemanniana M = S2 × S2 = �(p, q) ∈ R3 × R3 : |p| = |q| = 1�,
con la métrica producto, donde S2 es la esfera unitaria en R3. El plano tangente a M en
el punto m = (p, q) de M , denotado por TmM, es muy útil para encontrar el tensor de
curvatura, y se puede ver que está dado por
TmM = {(u,w) ∈ R3 × R3 | �u, p� = �w, q� = 0},
donde �·, ·� denota el producto interno ordinario sobre R3.
Deﬁniendo el tensor de curvatura y la curvatura escalar de una variedad riemanniana
(Mn, g) ⊂ Rr, de dimensión n > 2, podemos describir completamente la variedad salvo
movimientos en el espacio Rr.
0Palabras y frases claves: campo vectorial, conexión Levi Civita, tensor de curvatura y curvatura
escalar.
Key words: vector ﬁeld, Levi Civita connection, curvature tensor and scalar curvature.
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